top of page
double IHC.png

Distinguished Speakers

hans.jpg

Hans Clevers, MD, PhD

Topic: Organoids to model human disease

Hubrecht Institute for Developmental Biology and Stem Cell Research

w200.jpg

Paola Perego, PhD

Topic: Overcoming platinum resistance in ovarian carcinoma

National Tumor Institute of Milan, Italy

2020 Speakers

Organoids to model human disease Hans Clevers, MD, PhD Hubrecht Institute for Developmental Biology and Stem Cell Research Ovarian cancer prevention and early detection Douglas Levine, MD, FACOG, FACS New York University Langone Molecular Assessment of Circulating Extracellular Vesicles Towards Liquid Biopsy Diagnosis and Early Detection of Ovarian Cancer Andrew Godwin, PhD University of Kansas Medical Center Treatment of Advanced Ovarian Cancer Using Gene-edited NK CAR cells Timothy Starr, PhD University of Minnesota LRRC15 is a novel promoter of ovarian cancer metastatic dissemination Viji Shridhar, PhD Mayo Clinic Achieving Health Equity in Ovarian Cancer: The Role of DEI and Research Ana Núñez, MD, FACP University of Minnesota Ovary and Brain Martina Bazzaro, PhD University of Minnesota Drug resistance in ovarian cancer Scott Kaufmann, MD, PhD Mayo Clinic

Effect of the germline P72R polymorphism on the mutant TP53 allele selection in human cancer Jeremy Chien, PhD University of California, Davis Precision Medicine Opportunities for Endometrioid Ovarian Carcinoma: Lessons from Endometrial Cancer Michael Anglesio, PhD University of British Columbia Mechanisms of ovarian cancer metastasis to the omentum Ernst Lengyel, MD, PhD University of Chicago Overcoming platinum resistance in ovarian carcinoma Paola Perego, PhD National Tumor Institute of Milan, Italy Tumor Heterogeneity Ilana Chefetz, PhD The Hormel Institute, University of Minnesota PARP inhibitor response in PDX models: beyond HRD John Weroha, MD, PhD Mayo Clinic Mesenchymal stem cells are a TME lynch pin driving tumor immune suppression Ron Buckanovich, MD, PhD Magee-Womens Research Institute Early tubal precursors lead to nervous tumors Ronny Drapkin, MD, PhD University of Pennsylvania

bottom of page